A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Blue Earth Therapeutics Ltd
Blue Earth Therapeutics Ltd
SpectronRX
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Michigan Rogel Cancer Center
University of California, San Francisco
Wake Forest University Health Sciences
University of California, Davis
Rutgers, The State University of New Jersey
Johns Hopkins University
University Hospital, Bordeaux
Johns Hopkins University